amrinone has been researched along with olprinone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endoh, M; Satoh, H | 1 |
| Fujishima, K; Hachisu, M; Yamamoto, A | 1 |
| Baba, T; Goto, Y; Kanda, M; Noguchi, T; Nonogi, H; Sumida, H; Yasuda, S | 1 |
| Iribe, G; Matsunaga, A; Yamada, H; Yoshimura, N | 1 |
| Akamatsu, H; Maekawa, N; Mikawa, K; Nishina, K; Niwa, Y; Obara, H; Shiga, M | 1 |
| Furuya, H; Ishimaru, K; Kawaraguchi, Y; Kitaguchi, K; Sha, K; Shimokawa, M; Takahashi, M; Yanaidani, F | 1 |
| Fukuda, H; Hirabayashi, Y; Igarashi, T; Saitoh, K; Shimizu, R; Suzuki, H | 1 |
| Goto, S; Handa, S; Hoshiba, Y; Ikeda, Y; Kumagai, A; Sadiq, A; Tamura, N; Tanabe, T; Yoshida, M | 1 |
| Kanmura, Y; Matsumoto, K; Onomoto, M; Sakata, R; Suehiro, S; Tsuneyoshi, I; Yonetani, A | 1 |
| Adachi, H; Kakiki, M; Kishi, Y | 1 |
| Kobayashi, T | 1 |
2 trial(s) available for amrinone and olprinone
| Article | Year |
|---|---|
Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism.
Topics: Amrinone; Analysis of Variance; Blood Gas Analysis; Cardiac Surgical Procedures; Hemodynamics; Humans; Imidazoles; Liver; Middle Aged; Milrinone; Oxygen; Phosphodiesterase Inhibitors; Postoperative Care; Prospective Studies; Pyridones; Splanchnic Circulation | 2000 |
[Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
Topics: Aged; Amrinone; Cardiopulmonary Bypass; Female; Heart Valve Diseases; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Postoperative Care; Pyridones | 2000 |
9 other study(ies) available for amrinone and olprinone
| Article | Year |
|---|---|
Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.
Topics: Amrinone; Animals; Bupranolol; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Female; Heart; Heart Ventricles; Imidazoles; In Vitro Techniques; Isometric Contraction; Isoproterenol; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Pyridones | 1990 |
[Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].
Topics: Amrinone; Animals; Cardiotonic Agents; Dogs; Female; Femoral Artery; Hemodynamics; Imidazoles; Male; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Renal Circulation; Vasodilator Agents | 1998 |
Diuretic effect of phosphodiesterase inhibitors depends on baseline renal function in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Creatinine; Diuresis; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Treatment Outcome | 1999 |
The effect of phosphodiesterase III inhibitors on human neutrophil function.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Calcium; Cell-Free System; Cells, Cultured; Chemotaxis, Leukocyte; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Imidazoles; Milrinone; Neutrophils; Phagocytosis; Phosphodiesterase Inhibitors; Pyridones; Reactive Oxygen Species | 2000 |
Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression.
Topics: Amrinone; Anesthetics, Local; Animals; Bupivacaine; Depression, Chemical; Dogs; Electrocardiography; Female; Hemodynamics; Imidazoles; Male; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Time Factors | 2000 |
Possible contribution of acetylamrinone and its enhancing effects on platelet aggregation under shear stress conditions in the onset of thrombocytopenia in patients treated with amrinone.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Amrinone; Cyclic Nucleotide Phosphodiesterases, Type 3; Humans; Imidazoles; In Vitro Techniques; Phosphodiesterase Inhibitors; Platelet Aggregation; Pyridones; Stress, Mechanical; Thrombocytopenia | 2003 |
Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amrinone; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelium, Vascular; Gastroepiploic Artery; Humans; Imidazoles; In Vitro Techniques; Mammary Arteries; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Radial Artery; Vasodilation | 2005 |
Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Amrinone; Calcium Channel Blockers; Cyclic Nucleotide Phosphodiesterases, Type 3; Diltiazem; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gastroepiploic Artery; Humans; Imidazoles; In Vitro Techniques; Milrinone; Muscle, Smooth, Vascular; Pyridones; RNA, Messenger; Time Factors; Vasodilation | 2005 |
A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Topics: Amrinone; Animals; Heme Oxygenase-1; Hepatectomy; Hepatic Veno-Occlusive Disease; Imidazoles; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Pyridones; Rats; Reperfusion Injury; Up-Regulation | 2010 |